Definitive Contract 75R60220C00008

Award Date 7/10/20
Potential Completion Date 9/3/35
Potential Value $32M
Federal Agency
Headquarters
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Durham, NC 27705, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
6
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $12,160,266.00 firm-fixed-price definitive contract awarded by the Health Resources and Services Administration (HRSA) to Lifesouth Community Blood Centers Inc., a non-profit organization, for the National Cord Blood Inventory (NCBI) program. The contract has a 15-year period of performance ending in September 2034. The contract was awarded as part of a full and open competition to build and maintain the NCBI, which aims to collect and preserve at least 150,000 new, genetically diverse...
The Department of Health and Human Services Health Resources and Services Administration (HRSA) awarded a $13,800,876 definitive, firm-fixed-price contract to The Abraham J & Phyllis Katz Cord Blood Foundation, doing business as the Cleveland Cord Blood Center, a non-profit organization and manufacturer of goods. The contract supports the National Cord Blood Inventory (NCBI) program, which aims to build a repository of at least 150,000 new, genetically diverse cord blood units for...
The Department of Health and Human Services awarded a $12,313,923 firm fixed price contract to the New York Blood Center (NYBC), a nonprofit organization, to collect and maintain genetically diverse, high-quality umbilical cord blood units for the National Cord Blood Inventory. This is part of the 5th cohort of the Cord Blood Inventory program. The contract has an ultimate completion date of September 24, 2028 and was awarded on September 10, 2010. There was no set-aside designation for this...
This is a Definitive Contract awarded by the U.S. Headquarters agency, a civilian agency, to the non-profit organization Gencure (d/b/a The Texas Cord Blood Bank) on September 13, 2007. The contract is for $8,223,699.00 and is a Firm Fixed Price Contract for Management Services/Contract and Procurement Support for the National Cord Blood Inventory Augmentation, Second Cohort. The contract has no set-aside designation and is set to expire on June 12, 2026. The major program code is MGT...
This is a $2,019,992 cost-plus-fixed-fee delivery order contract awarded by the Department of Health and Human Services (DHHS) to The Mitre Corporation, a non-profit organization, for the National Cord Blood Inventory (NCBI) statutory and programmatic analysis for the Health Resources and Services Administration (HRSA). The contract has an ultimate completion date of September 29, 2025. Mitre is an FFRDC that provides scientific, technical, and acquisition support services to the U.S....
The U.S. Health Resources and Services Administration (HRSA) awarded a $123,734,082 single-award, firm-fixed price contract to the National Marrow Donor Program (doing business as Be The Match), a non-profit organization, to establish and maintain an electronic system allowing healthcare professionals to search for adult bone marrow donors and cord blood units on behalf of patients through a Single Point of Access - Coordinating Center (SPA-CC). This contract, which has a performance period of...
This is a $6,792,405.00 definitive contract awarded by the Department of Health and Human Services (HHS) to Bloodworks, a non-profit organization doing business as Puget Sound Blood Center and Program. The contract is for management services and contract and procurement support, and is part of the Cord Blood Inventory program under award #4. The contract is a firm fixed price arrangement without any set-aside designation. In addition to this contract award, Bloodworks holds several significant...
This is a $29,563,729 firm-fixed price contract awarded by the Health Resources and Services Administration (HRSA) to The Medical College of Wisconsin, Inc. (MCW) to establish and maintain the Stem Cell Therapeutic Outcomes Database (SCTOD). The SCTOD collects and analyzes clinical data on patients who have received stem cell transplants, including bone marrow or cord blood. The contract has a base period through March 2028, with no small business set-aside. MCW has subcontracted a portion of...
This federal contract award, valued at $142,516.20, was issued by the National Institutes of Health (NIH) Clinical Center to the American Association of Blood Banks, Inc. (AABB), a non-profit organization. The contract is a firm fixed-price purchase order that does not have a set-aside designation. Under this contract, AABB will provide the NIH Clinical Center with a variety of blood products, including red blood cells, platelets, and fresh frozen plasma, to support the center's research...
This is a federal contract award to Wicell Research Institute, Inc., a non-profit organization, by the National Heart Lung and Blood Institute, a component of the U.S. Department of Health and Human Services. The contract, valued at $16,137,048.00, is for the provision of human pluripotent stem cell lines, testing, and related services to support biomedical research. Wicell is a global leader in stem cell banking and distribution, and has provided specific cell lines to the National Institutes...

This contract was awarded by the Health Resources and Services Administration (HRSA) to Duke University to support the National Cord Blood Inventory (NCBI) program. The NCBI is a statutory initiative to build a nationwide inventory of at least 150,000 new, genetically diverse cord blood units for hematopoietic stem cell transplantation. Under this $31,801,048.00 firm-fixed-price contract, Duke University will operate an established cord blood bank, add licensed cord blood units from diverse donors to the public inventory, and make the units available through the C.W. Bill Young Cell Transplantation Program and for peer-reviewed research. The contract has an initial 5-year period of performance with options to extend for up to 10 additional years. This contract award was made on a full and open basis without any set-aside designations.

Generated 7/11/25, 10:08 AM